The French clinical stage company focused on cardiac innovation received the funds from a Series C funding round and the EC’s ...

Scientists at the Institute of Molecular Biotechnology (IMBA) of the Austrian Academy of Sciences have developed a multi-chamber organoid that mirrors the heart’s intricate structure. The human ...

A study led by Maria Carmo-Fonseca at GIMM has helped clarify one of the main limitations of lab-grown heart cells, which are ...

Heart disease kills 18 million people each year, but the development of new therapies faces a bottleneck: no physiological model of the entire human heart exists – so far. A new multi-chamber organoid ...

Heart disease kills 18 million people each year, but the development of new therapies faces a bottleneck: no physiological model of the entire human heart exists – so far. A new multi-chamber organoid ...

Having explored how the heart is formed in utero, a University of Houston pharmacology researcher is reporting how cells and molecules act during that early formation and what might cause the heart ...

Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment by using the patient's own T-cells to target tumors.

As someone who finds the field of science fascinating, I often consider the roles that human and veterinary medicine play in advancing science, particularly through cardiac surgical programs. With ...

Financial and geographic disparities contributing to elevated risk for heart disease are explored. This is a video synopsis/summary of a panel discussion involving Robert Groves, MD; Eugene E. Wright ...